NCT02451839View on ClinicalTrials.gov

An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)

CompletedOBSERVATIONAL

Enrollment

168

Participants

Timeline

Start Date

July 6, 2015

Primary Completion Date

December 5, 2017

Study Completion Date

December 5, 2017

Conditions

Crohn's DiseaseRheumatoid ArthritisPsoriasis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY

NCT02451839 - An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) | Biotech Hunter | Biotech Hunter